智通财经APP获悉，春立医疗(01858)涨超3%，截至发稿，涨3.15%，报9.81港元，成交额526.53万港元。
消息面上，近日，春立医疗发布2025年第一季度报告，该集团取得营业收入2.3亿元，同比增加3.6%；归属于上市公司股东的净利润5807.11万元，同比增加5.2%；基本每股收益0.15元。华创证券发布研报指出，公司24Q4实现归母净利润0.64亿元，实现环比Q3扭亏，25Q1实现归母净利润0.58亿元(+5.20%)，同比增长。预计集采导致的渠道退换货基本结束，集采影响逐渐出清，有望重回增长。
该行续指，受益于公司长期较高的研发投入，新产品不断获批。25年1-4月期间，公司的正畸支抗钉、电池供电骨组织手术设备、牙科聚合物基复合树脂、钛网板系统、非融合棘突植入物、光固化流动树脂、自稳定型椎间融合器等多个产品获批，公司口腔产品线得到完善，并进一步增长骨科产品体系竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.